• In late June 2026, Zions Bancorporation, National Association (NasdaqGS: ZION) was added to both the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index, reflecting its classification within these defensive equity benchmarks.
• This dual inclusion highlights how index providers currently view Zions as aligning with more resilient, value-oriented banking names, which can influence how institutional investors allocate capital to the stock.
• We’ll now examine how Zions’ addition to the Russell 1000 defensive indexes intersects with its existing investment narrative and risk profile.

The latest GPUs need a type of rare earth metal called Neodymium and there are only 30 companies in the world exploring or producing it. Find the list for free.

Zions Bancorporation National Association Investment Narrative Recap

To own Zions today, you need to be comfortable with a regional bank thesis built around disciplined risk management, steady profitability and slower growth relative to the broader US market. Its addition to the Russell 1000 Defensive and Value Defensive indexes reinforces that positioning but does not materially change the near term balance between the key catalyst of improving efficiency and the ongoing risks from geographic concentration, deposit mix pressures and commercial real estate exposure.

Among recent announcements, the board’s appointment of former PwC partner Daniel J. Ryan as a director and member of the Audit and Risk Oversight Committees is most relevant here, because index inclusion that emphasizes defensiveness sits alongside an explicit focus on governance, controls and risk monitoring. For investors weighing Zions’ earnings quality, capital returns and exposure to Western US cycles, this combination frames how resilient the bank may prove if credit conditions become more challenging.

Yet behind the new “defensive” label, investors should be aware that concentrated CRE and regional exposures could still...

Zions Bancorporation National Association's narrative projects $3.8 billion revenue and $964.5 million earnings by 2029.

Uncover how Zions Bancorporation National Association's forecasts yield a $69.43 fair value, in line with its current price.

Exploring Other Perspectives

Three fair value estimates from the Simply Wall St Community span from about US$69 to over US$44,000 per share, showing just how far apart individual views can be. Set against Zions’ concentration in Western US markets and its meaningful commercial real estate book, this wide spread underlines why you may want to compare several perspectives before deciding how resilient the current investment case really is.

Explore 3 other fair value estimates on Zions Bancorporation National Association - why the stock might be worth just $69.43!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Zions Bancorporation National Association research is our analysis highlighting 4 key rewards that could impact your investment decision.
• Our free Zions Bancorporation National Association research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Zions Bancorporation National Association's overall financial health at a glance.

Interested In Other Possibilities?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
• Capitalize on the AI infrastructure supercycle with our selection of the 51 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.